BROWSE·page 4 of 1380

Browse EX-10 agreements

16,554 total material contract exhibits.


EX-10.1

FF EAI Robotics Ecosystem Inc.


TRANSITION SERVICES AGREEMENT

** **

This Transition Services Agreement (this “Agreement”), effective as of October 1, 2026 (the “Effective Date”), is made by and between Faraday Future Intelligent Electric Inc. (the “Provider”), FF EAI Robotics Inc. (the “Recipient”) and FF EAI Robotics Ecosystem Inc (the “Purchaser”) (solely for purpose of Sections 2.1, 5.1, 5.2, 6.4 and 11.1). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Transaction Agreement (defined below).

WHEREAS, the Recipient desires to engage the Provider from time-to-time to provide certain services (the “Services”) as more fully described in a Statement of Work in substantially the same form as Exhibit A attached hereto, and the Provider is offering to provide such Services to the Recipient in accordance with the terms of this Agreement.

…

EX-10.1·8-K·CIK 1460702·ACC 0001493152-26-046927·Filed Oct 14, 2026, 07:32 ET

EX-10.5

FF EAI Robotics Ecosystem Inc.

** **


FORM OF** SECURITIES PURCHASE AGREEMENT**

** **

This Securities Purchase Agreement (this “Agreement”) is dated as of October 12, 2026 by and among FF EAI Robotics Ecosystem Inc. (formerly known as “AIxCrypto Holdings, Inc.”), a Delaware corporation (the “Company”) and the purchasers listed on Schedule I hereto (each, a “Purchaser” and collectively, the “Purchasers”). Each of the Company and the Purchasers is referred to herein individually as a “Party” and collectively as the “Parties.”

WHEREAS, concurrently with the execution of this Agreement, on October 12, 2026, the Company has entered into the Acquisition Agreement, pursuant to which, among other things, the Company will acquire from Smart Technology Holdings Ltd., a wholly owned subsidiary of FFAI, all of the issued and outstanding capital stock of RobotCo in exchange for the FF Consideration Securities, and RobotCo will thereafter merge with and into a wholly owned subsidiary of the Company;

…

EX-10.5·8-K·CIK 1460702·ACC 0001493152-26-046927·Filed Oct 14, 2026, 07:32 ET

EXHIBIT 10.5

Liquidia Corp

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS
EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION
THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

SEVENTH AMENDMENT TO THE REVENUE INTEREST FINANCING AGREEMENT

This SEVENTH AMENDMENT TO THE REVENUE INTEREST FINANCING AGREEMENT (this “Amendment”), dated as of October 13, 2026 (the “Seventh Amendment Effective Date”), is entered into by and between Liquidia Technologies, Inc., a Delaware corporation (the “Company”), and Healthcare Royalty Partners IV, L.P., a Delaware limited partnership, as the sole Investor and Investor Representative under the Agreement (as defined below) (the “Investor Representative”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement (as defined below).

RECITALS

…

EX-10.5·8-K·CIK 1819576·ACC 0001104659-26-115672·Filed Oct 13, 2026, 21:49 ET

EXHIBIT 10.2

Liquidia Corp

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

SETTLEMENT AND TERMINATION AGREEMENT

This Settlement and Termination Agreement (this “Agreement”) is entered into as of October 11, 2026, between Liquidia Technologies, Inc., a Delaware corporation (“Liquidia”), and Sandoz Inc., a Delaware corporation (“Sandoz”). Capitalized terms used but not defined in this Agreement have the meanings given in the Promotion Agreement (as defined below).

RECITALS:

…

EX-10.2·8-K·CIK 1819576·ACC 0001104659-26-115672·Filed Oct 13, 2026, 21:49 ET

EXHIBIT 10.1

Liquidia Corp

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

SETTLEMENT AGREEMENT

This Settlement Agreement (this “Agreement”) is made and entered into as of the last date of signature of this Agreement (the “Execution Date”), by and between United Therapeutics Corporation, a Delaware public benefit corporation with a principal place of business at 1000 Spring Street, Silver Spring, Maryland 20910 (“UTC”), and Liquidia Technologies, Inc., a corporation organized and existing under the laws of Delaware, with a principal place of business at 419 Davis Drive, Suite 100, Morrisville, North Carolina 27560 (“Liquidia”) (each of UTC and Liquidia may be referred to herein, individually, as a “Party” and, together, as the “Parties”).

WHEREAS, the Parties have been and/or are engaged in the Contested Proceedings (as defined below);

…

EX-10.1·8-K·CIK 1819576·ACC 0001104659-26-115672·Filed Oct 13, 2026, 21:49 ET

EXHIBIT 10.3

Liquidia Corp

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

SETTLEMENT AND TERMINATION AGREEMENT

This Settlement and Termination Agreement (this “Agreement”) is entered into as of October 8, 2026, between Liquidia PAH, LLC (previously named RareGen, LLC), a Delaware limited liability company (“RareGen”), and its parent company, Liquidia Technologies, Inc., a Delaware corporation (“Liquidia” and together with RareGen, the “RareGen Parties”), and Henderson SPV, LLC, a Delaware limited liability company (“Financer”). Capitalized terms used but not defined in this Agreement have the meanings given in the Financing Agreement (as defined below).

RECITALS:

A. Financer and RareGen are parties to that certain Financing Agreement, dated as of June 4, 2020 (as amended, supplemented or otherwise modified from time to time, the “Financing Agreement”).

…

EX-10.3·8-K·CIK 1819576·ACC 0001104659-26-115672·Filed Oct 13, 2026, 21:49 ET

EXHIBIT 10.4

Liquidia Corp

**CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT
 BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE
REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. **

[***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

SETTLEMENT AND TERMINATION AGREEMENT

This Settlement and Termination Agreement (this “Agreement”) is entered into as of October 10, 2026, between Liquidia PAH, LLC (previously named RareGen, LLC), a Delaware limited liability company (“RareGen”), and its parent company, Liquidia Technologies, Inc., a Delaware corporation (“Liquidia” and together with RareGen, the “Liquidia Parties”), and PBM RG Holdings, LLC, a Delaware limited liability company (“PBM”). Capitalized terms used but not defined in this Agreement have the meanings given in the Indemnification Agreement (as defined below).

RECITALS:

…

EX-10.4·8-K·CIK 1819576·ACC 0001104659-26-115672·Filed Oct 13, 2026, 21:49 ET

REGISTRATION RIGHTS AGREEMENT

** **

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2026, is made and entered into by and between Spring Valley Acquisition Corp. V, a Cayman Islands exempted company (the “Company”), Spring Valley Acquisition V Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), Cohen & Company Capital Markets, a division of Cohen and Company Securities, LLC (the “Representative”), and the other undersigned parties listed under Holders on the signature page hereto (the Sponsor, the Representative, such other parties, together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

** **

…

EX-10.5·S-1/A·CIK 2138170·ACC 0001213900-26-109177·Filed Oct 13, 2026, 19:14 ET

**FORM OF PRIVATE PLACEMENT WARRANT SUBSCRIPTION AGREEMENT **

BETWEEN

SPRING VALLEY ACQUISITION CORP. V

AND

THE UNDERWRITERS

THIS PRIVATE PLACEMENT WARRANT SUBSCRIPTION AGREEMENT, dated as of [●], 2026 (as it may from time to time be amended, this “Agreement”), is entered into by and between Spring Valley Acquisition Corp. V, a Cayman Islands exempted company (the “Company”), and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one Class A Ordinary Share, par value $0.0001 per share, of the Company (an “Ordinary Share”), and one-fifth of one redeemable public warrant, as set forth in the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”), File No. 333-296571 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”); and

…

EX-10.7·S-1/A·CIK 2138170·ACC 0001213900-26-109177·Filed Oct 13, 2026, 19:14 ET

** **

[   ], 2026

Spring Valley Acquisition Corp. V

4030 Maple Avenue, Suite 500

Dallas, TX 75219

Re: Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Spring Valley Acquisition Corp. V, a Cayman Islands exempted company (the “Company”), Cohen & Company Capital Markets, a division of Cohen and Company Securities, LLC, as representative (the “Representative”) of the underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 23,000,000 of the Company’s units (including up to 3,000,000 units which may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one Class A ordinary share, par value US $0.0001 per share, of the Company (the “Class A Ordinary Shares”) and one-fifth of one redeemable public warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one

…

EX-10.3·S-1/A·CIK 2138170·ACC 0001213900-26-109177·Filed Oct 13, 2026, 19:14 ET

PRIVATE PLACEMENT WARRANT SUBSCRIPTION AGREEMENT

THIS PRIVATE PLACEMENT WARRANT SUBSCRIPTION AGREEMENT, dated as of [ ], 2026 (as it may from time to time be amended, this “Agreement”), is entered into by and between Spring Valley Acquisition Corp. V, a Cayman Islands exempted company (the “Company”), and Spring Valley Acquisition V Sponsor, LLC, a Delaware limited liability company (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one Class A Ordinary Share, par value $0.0001 per share, of the Company (an “Ordinary Share”), and one-fifth of one redeemable public warrant, as set forth in the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”), File No. 333-296571 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”); and

…

EX-10.6·S-1/A·CIK 2138170·ACC 0001213900-26-109177·Filed Oct 13, 2026, 19:14 ET

FORM OF ADMINISTRATIVE SERVICES AGREEMENT

Spring Valley Acquisition Corp. V

**Exhibit 10.9 **

** **

Spring Valley Acquisition Corp. V

4030 Maple Avenue, Suite 500

Dallas, TX 75219

[        ], 2026

Spring Valley Acquisition V Sponsor, LLC

4030 Maple Avenue, Suite 500

Dallas, TX 75219

Ladies and Gentlemen:

This letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration Statement”) for the initial public offering of the securities (the “IPO”) of Spring Valley Acquisition Corp. V (the “Company”) and continuing until the earlier of (i) the consummation by the Company of an initial business combination or (ii) the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”), Spring Valley Acquisition V Sponsor, LLC (the “Sponsor”) shall make available to the Company certain office space, utilities and secretarial and administrative support as may be required by the Company from time to time, situated at 4030 Maple Avenue, Suite 500, D

…

EX-10.9·S-1/A·CIK 2138170·ACC 0001213900-26-109177·Filed Oct 13, 2026, 19:14 ET